Grant: Operating Grant
Sunnybrook Research Institute (Toronto, Ontario)
$734,129.00
Novel Regulators of Mitochondrial Dynamics
FY 2014-15
Summary
Type 1 and Type 2 Diabetes are major health concerns for Canadians. Loss of function of the pancreatic beta cell which is responsible for insulin secretion and thus for regulating blood sugar levels, is a central feature of both T1D and T2D. Pancreatic beta cells and neurons are highly similar cells, like they were 'separated at birth'. Key to the function and survival of beta cells is the integrity of mitchondria, essential cellular organelles required for cells to use energy from food. Indeed, mitochondrial damage is a hallmark of diabetes. Accumulation of damaged mitochondria is also now thought to underlie symptoms Parkinson Disease, which is characterized by the degeneration of brain cells that are required for normal movement leading to chronic disability. Our recent work has shown that the protein ROMO1 is required to promote mitochondrial health and cell survival. This application seeks to establish a comprehensive framework for the physiological significance of the ROMO1 pathway in pancreatic beta cells and neurons. The long-term goal of this work is to provide a new list of targets for therapeutic intervention with the goal of prolonging beta cell and neuronal survival to improve patient survival and quality of life.
Department
Program
Operating Grant
Location
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
322482
Name
Screaton Robert A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Cell Physiology
Projecttitle
Novel Regulators of Mitochondrial Dynamics
Programtype2
Operating Grants
Orgnameinp2
Sunnybrook Research Institute (Toronto, Ontario)
Cihramount2
$734,129
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Apoptosis; Cell Signaling; Knockout Mouse Models; Mitochondria; Mitochondrial Dynamics; Mitophagy; Neurons; Pancreatic Beta Cells; Parkin; Romo1
Abstract
Type 1 and Type 2 Diabetes are major health concerns for Canadians. Loss of function of the pancreatic beta cell which is responsible for insulin secretion and thus for regulating blood sugar levels, is a central feature of both T1D and T2D. Pancreatic beta cells and neurons are highly similar cells, like they were 'separated at birth'. Key to the function and survival of beta cells is the integrity of mitchondria, essential cellular organelles required for cells to use energy from food. Indeed, mitochondrial damage is a hallmark of diabetes. Accumulation of damaged mitochondria is also now thought to underlie symptoms Parkinson Disease, which is characterized by the degeneration of brain cells that are required for normal movement leading to chronic disability. Our recent work has shown that the protein ROMO1 is required to promote mitochondrial health and cell survival. This application seeks to establish a comprehensive framework for the physiological significance of the ROMO1 pathway in pancreatic beta cells and neurons. The long-term goal of this work is to provide a new list of targets for therapeutic intervention with the goal of prolonging beta cell and neuronal survival to improve patient survival and quality of life.
Competitiondate
201503
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Screaton, Robert A
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $734,129~ $0~